Lancet Oncology

Published by: Elsevier Science, Inc.  

People

  1. Garcia Aguilar
    Garcia Aguilar
  2. Moskowitz
    Moskowitz
  3. Schoder
    Schoder
  4. Balachandran
    Balachandran
  5. Bilsky
    Bilsky
  6. Brady
    Brady
  7. Brennan
    Brennan
  8. D'Angelo
    D'Angelo
  9. Giralt
    Giralt
  10. Gonen
    Gonen

Groups

  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (7)
  3. Surgery (6)
  4. Hematologic Malignancies, Division of (5)
  5. Center for Hematologic Malignancies (4)
  6. GSK Faculty (4)
  7. Colorectal Surgery (3)
  8. Genitourinary Oncology Service (3)
  9. Melanoma and Immunotherapeutics Service (3)
  10. Radiology, Department of (3)
Search Within
  1. "2015"
Formats
  1. Journal Article (21)
Groups
  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (7)
  3. Surgery (6)
  4. Hematologic Malignancies, Division of (5)
  5. Center for Hematologic Malignancies (4)
  6. GSK Faculty (4)

More Groups

People
  1. Jedd Wolchok (3)
  2. Alison Moskowitz (2)
  3. Craig Moskowitz (2)
  4. Heiko Schoder (2)
  5. Julio Garcia Aguilar (2)
  6. Oliver Chow (2)

More People

Years
  1. 2015 (21)
Publishers
  1. Elsevier Science, Inc. (21)

Results (21)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): A randomised, double-blind, phase 3 trial
    Journal Article

    Eggermont, A. M. M.; Chiarion-Sileni, V.; Grob, J. J.; Dummer, R.; Wolchok, J. D.; Schmidt, H.; Hamid, O.; Robert, C.; Ascierto, P. A.; Richards, J. M.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Response assessment after stereotactic body radiotherapy for spinal metastasis: A report from the SPIne response assessment in Neuro-Oncology (SPINO) group
    Journal Article

    Thibault, I.; Chang, E. L.; Sheehan, J.; Ahluwalia, M. S.; Guckenberger, M.; Sohn, M. J.; Ryu, S.; Foote, M.; Lo, S. S.; Muacevic, A.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Busulfan-based conditioning regimens: Not all partners are equal
    Journal Article

    Giralt, S.
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): Results of an open-label, single-arm, multi-institutional, phase 2 trial
    Journal Article

    Garcia-Aguilar, J.; Renfro, L. A.; Chow, O. S.; Shi, Q.; Carrero, X. W.; Lynn, P. B.; Thomas, C. R.; Chan, E.; Cataldo, P. A.; Marcet, J. E.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: A randomised, phase 2, open-label, multicentre trial
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Glen, H.; Michaelson, M. D.; Molina, A.; Eisen, T.; Jassem, J.; Zolnierek, J.; Maroto, J. P.; Mellado, B.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Global cancer surgery: Delivering safe, affordable, and timely cancer surgery
    Journal Article

    Sullivan, R.; Alatise, O. I.; Anderson, B. O.; Audisio, R.; Autier, P.; Aggarwal, A.; Balch, C.; Brennan, M. F.; Dare, A.; D'Cruz, A.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Consensus on biomarkers for neuroendocrine tumour disease
    Journal Article

    Oberg, K.; Modlin, I. M.; De Herder, W.; Pavel, M.; Klimstra, D.; Frilling, A.; Metz, D. C.; Heaney, A.; Kwekkeboom, D.; Strosberg, J.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): A randomised, controlled, double-blind, multinational, phase 3 study
    Journal Article

    Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; Erba, H. P.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Adjuvant radiation for patients with melanoma
    Journal Article

    Brady, M. S.
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: A multicentre, phase 2 trial
    Journal Article

    Garcia-Aguilar, J.; Chow, O.S.; Smith, D. D.; Marcet, J. E.; Cataldo, P. A.; Varma, M. G.; Kumar, A. S.; Oommen, S.; Coutsoftides, T.; Hunt, S. R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save

    • Lancet Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Lancet Oncology 1470-2045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 The Lancet Publishing Group
    Lancet Oncology 1470-2045 Elsevier B.V.
    Lancet Oncology 14702045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 Elsevier Inc.
    Lancet Oncology 14702045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 Elsevier Inc.
    Lancet Oncology 1470-2045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 Elsevier Science, Inc.
    Lancet Oncology 0094-0143 Unknown
    Lancet Oncology 0732-183X Unknown
    Lancet Oncology 1089-9472 Unknown
    Lancet Oncology 0938-7994 Unknown
    Lancet Oncology 2314-6133 Unknown
    Lancet Oncology 2152-2650 Unknown
    Lancet Oncology 1471-2407 Unknown
    Lancet Oncology 1470-2045 Elsevier Science, Inc.
    Lancet Oncology 1470-2045 Unknown
    Lancet Oncology 1470-2045 The Lancet Publishing Group
    Lancet Oncology 14702045 Elsevier Inc.
    Lancet Oncology 14702045 Unknown
    The Lancet Oncology 1470-2045 Elsevier Science, Inc.
    The Lancet Oncology 14745488 Elsevier Inc.
    The Lancet Oncology 14745488 Elsevier Inc.
    The Lancet Oncology 14745488 Unknown
    The Lancet Oncology 1474-5488 Elsevier Inc.
    The Lancet Oncology 14702045 Elsevier Inc.
    The Lancet Oncology 14702045 Unknown
    The Lancet Oncology 1470-2045 Elsevier Inc.
    The Lancet. Oncology 1474-5488 Unknown
    The Lancet. Oncology 14745488 Unknown